The application of toxins and venoms to cardiovascular drug discovery

W HODGSON, Geoffrey Isbister

    Research output: Contribution to journalArticlepeer-review


    Animal venoms contain a variety of highly selective and potent toxins, which have evolved over thousands/millions of years, which target vital physiological processes. As such, they have proven to be an excellent source of lead compounds for the development of therapeutic agents. In particular, a number of these venom components (e.g. bradykinin-potentiating peptides, sarafotoxins, natriuretic peptides) have profound effects on the cardiovascular system. This review article examines recent progress in the search for lead compounds or novel scaffolds for cardiovascular drug development from animal venoms. � 2008 Elsevier Ltd. All rights reserved.
    Original languageEnglish
    Pages (from-to)173-176
    Number of pages4
    JournalCurrent Opinion in Pharmacology
    Issue number2
    Publication statusPublished - 2009


    Dive into the research topics of 'The application of toxins and venoms to cardiovascular drug discovery'. Together they form a unique fingerprint.

    Cite this